Greg Zuo

Greg Zuo has a diverse work experience spanning over two decades. Greg is currently serving as the CFO and Executive Director at GeneCast Biotechnology Co., Ltd., a leading cancer molecular diagnostics and testing company in China. In this role, Greg is responsible for assisting doctors' decision-making in cancer treatment through comprehensive testing.

Prior to GeneCast, Greg held the position of CFO and Chief Strategy Officer at ONESMART Education Group, a prominent education organization in China. During their tenure, they contributed to the financial and strategic planning of the company from 2019 to 2021.

Greg also has experience in the investment industry. Greg worked at Goldman Sachs in the ASSG Investment Group from 2013 to 2019 and was an Investment Executive at Intermediate Capital Group from 2011 to 2013. Additionally, they served as Vice President of Global M&A at GE Capital from 2007 to 2010.

Before transitioning into the investment sector, Greg worked at MasterCard Worldwide as the Director of Corporate Finance at their New York Headquarters from 2004 to 2007. Greg began their career at PricewaterhouseCoopers in Shanghai, where they worked from 1998 to 2002.

Overall, Greg Zuo has a strong background in finance, strategy, and investment, with a focus on the healthcare, education, and technology sectors.

Greg Zuo received a B.E. in Industrial Foreign Trade from Shanghai Jiao Tong University. Greg later attended MIT Sloan School of Management from 2002 to 2004, where they obtained an MBA with a specialization in Finance.